TY - JOUR
T1 - Collagens in primary frozen shoulder
T2 - expression of collagen mRNA isoforms in the different phases of the disease
AU - Marker, Line
AU - Schjerling, Peter
AU - Mackey, Abigail L
AU - Hansen, Thomas
AU - Jakobsen, Jens
AU - Kjær, Michael
AU - Krogsgaard, Michael R
N1 - © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: [email protected].
PY - 2021/8/2
Y1 - 2021/8/2
N2 - OBJECTIVES: Primary frozen shoulder (pFS) has three phases that differ in clinical presentation. It is characterized by contracture of the joint capsule. We hypothesized that there is a general upregulation of collagens in pFS, and that this is highest in the first phase of the disease. The aims of this study were to investigate the expression of various collagens and degradation of collagens in patients with primary pFS and relate this to the three phases of the condition.METHODS: From twenty-six patients with pFS and eight control patients with subacromial impingement, biopsies were obtained during shoulder arthroscopy from the middle glenohumeral ligament and the anterior capsule, and mRNA levels for collagens, MMP-2 and -14 and TGF-β1, - β2 and -β3 in the tissue were analysed using real-time PCR.RESULTS: Genes for collagens type I, III, IV, V, VI and XIV, were activated in pFS, and the total mRNA for all collagens was increased (P < 0.05). This upregulation was independent of disease phases in pFS. In addition, MMP-2, MMP-14, TGF-β1 and TGF-β3 were upregulated in all phases of the disease.CONCLUSION: There is a general upregulation and an increased degradation of collagens in pFS in all three phases of the disease. This indicates a constantly increased turnover of the fibrotic tissue in the capsule from pFS. The difference in clinical presentation of pFS observed in the three phases of the disease is not primarily a result of variations in collagen production.
AB - OBJECTIVES: Primary frozen shoulder (pFS) has three phases that differ in clinical presentation. It is characterized by contracture of the joint capsule. We hypothesized that there is a general upregulation of collagens in pFS, and that this is highest in the first phase of the disease. The aims of this study were to investigate the expression of various collagens and degradation of collagens in patients with primary pFS and relate this to the three phases of the condition.METHODS: From twenty-six patients with pFS and eight control patients with subacromial impingement, biopsies were obtained during shoulder arthroscopy from the middle glenohumeral ligament and the anterior capsule, and mRNA levels for collagens, MMP-2 and -14 and TGF-β1, - β2 and -β3 in the tissue were analysed using real-time PCR.RESULTS: Genes for collagens type I, III, IV, V, VI and XIV, were activated in pFS, and the total mRNA for all collagens was increased (P < 0.05). This upregulation was independent of disease phases in pFS. In addition, MMP-2, MMP-14, TGF-β1 and TGF-β3 were upregulated in all phases of the disease.CONCLUSION: There is a general upregulation and an increased degradation of collagens in pFS in all three phases of the disease. This indicates a constantly increased turnover of the fibrotic tissue in the capsule from pFS. The difference in clinical presentation of pFS observed in the three phases of the disease is not primarily a result of variations in collagen production.
KW - Adult
KW - Biopsy
KW - Bursitis/genetics
KW - Case-Control Studies
KW - Collagen Type I/genetics
KW - Collagen Type III/genetics
KW - Collagen Type IV/genetics
KW - Collagen Type V/genetics
KW - Collagen Type VI/genetics
KW - Collagen/genetics
KW - Disease Progression
KW - Female
KW - Gene Expression
KW - Humans
KW - Joint Capsule/metabolism
KW - Ligaments/metabolism
KW - Male
KW - Matrix Metalloproteinase 14/genetics
KW - Matrix Metalloproteinase 2/genetics
KW - Middle Aged
KW - RNA, Messenger/metabolism
KW - Transforming Growth Factor beta1/genetics
KW - Transforming Growth Factor beta2/genetics
KW - Transforming Growth Factor beta3/genetics
KW - Up-Regulation
KW - collagen turnover
KW - fibroblasts
KW - disease activity
KW - frozen shoulder
U2 - 10.1093/rheumatology/keaa802
DO - 10.1093/rheumatology/keaa802
M3 - Journal article
C2 - 33347577
SN - 1462-0324
VL - 60
SP - 3879
EP - 3887
JO - Rheumatology (Oxford, England)
JF - Rheumatology (Oxford, England)
IS - 8
ER -